Sotuvning sof marjinal rentabelligi: calidibio.com (CLDI)

Calidi Biotherapeutics (CLDI) tovar belgisi

Yuqori binar xatarlar va tashqi moliyalashtirishga bog'liqlik Calidi Biotherapeutics (CLDI) kompaniyasiga bosim o'tkazmoqda. Biroq, o'simtalarga yo'naltirilgan virusli yetkazib berish uchun stam hujayralardan foydalanish va klinik sinovlarni autsorsing qilish kapital xarajatlarini kamaytirmoqda. Sof foyda marjasi tayanch darajasini namoyish etmoqda, bunda 0.00 qiymati tushumga nisbatan foydani boshqarish samaradorligining joriy ko'rsatkichi hisoblanadi.

Calidi Biotherapeutics Inc. (CLDI) - Kompaniya sotuv marjasi 21.02.2024dan 19.11.2026gacha

calidibio.com (CLDI) moliyaviy va bozor koʻrsatkichlari kesimi

- aksiya kursi va ekspertlarning narx prognozi:
- kompaniyaning birjadagi kapitallashuv ko'rsatkichlari:
Kompaniyaning barcha koʻrsatkichlari tahlili:Calidi Biotherapeutics
Calidi Biotherapeutics yetakchi tovari

Investorlar Calidi Biotherapeutics (CLDI) moliyaviy barqarorligini rentabellik koeffitsientlari tizimi orqali tekshirmoqdalar. Ushbu sof foyda marjasi barcha xarajatlar chegirib tashlanganidan keyin har bir dollar daromadning yakuniy foyda qismini aks ettiradi. Ushbu ko'rsatkichning salbiy tendentsiyasi Calidi Biotherapeutics uchun odatiy holdir, chunki kompaniya onkolitik viruslarning klinik sinovlariga e'tibor qaratmoqda. Joriy ishlab chiqish xarajatlari ishlab chiqarish ittifoqlaridan tushgan daromadlardan yuqoridir. Ushbu metrikani tahlil qilish kapitalning sarflanish sur'atini baholash imkonini beradi.

Raqobatdosh kompaniyalar tahlili

ONC: Sotuvning sof marjinal rentabelligi|Sof marja Halozyme Inc. (HALO)|Sof marja RevMed|Sotuvning sof rentabelligi AAPG (Ascentage Pharma Group)|Sotuvning sof marjinal rentabelligi CGON|UroGen Pharma - Sotuvning sof rentabelligi|Bicara Therapeutics - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof marjinal rentabelligi Personalis Inc PSNL|Erasca Oncology - Sotuvning sof marjinal rentabelligi|Sof foyda normasi DCTH (Delcath Corp)|YMAB: Sotuvning sof marjinal rentabelligi|AURA - Kompaniya sotuv marjasi|CADL (Candel Therapeutics Inc.) - Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi ARAY (Accuray)|Sof foyda bo'yicha sotuv rentabelligi SLS (SELLAS Life Sciences Group, Inc.)|ACTU - Sof marja|Sof marja Citius Oncology, Inc. CTOR|HURA - Sof foyda bo'yicha sotuv rentabelligi|protaratx.com - Sotuvning sof marjinal rentabelligi|FATE - Sotuvning sof marjinal rentabelligi|WHWK: Sotuvning sof marjinal rentabelligi|TScan Therapeutics (TCRX) - Sotuvning sof marjinal rentabelligi|Sof marja Champions Oncology|Sof marja XBIT|Sotuvning sof marjinal rentabelligi CVM|Sof foyda bo'yicha sotuv rentabelligi OS Therapies Inc. OSTX|Sof marja Radiopharm Theranostics Limited RADX|artivabio.com (ARTV) - Sof marja|ANL - Sof marja|Sof marja verupharma.com|TPST: Sotuvning sof marjinal rentabelligi|XLO - Kompaniya sotuv marjasi|Sof marja Renovaro|Sotuvning sof marjinal rentabelligi muraloncology.com|Sotuvning sof marjinal rentabelligi KAPA|Kompaniya sotuv marjasi OnKure Therapeutics, Inc.|Sotuvning sof marjinal rentabelligi GDTC (w2.cytomed.sg)|CRIS - Sof foyda bo'yicha sotuv rentabelligi|Apollomics - Sotuvning sof marjinal rentabelligi|Tharimmune Corp (THAR) - Sof foyda bo'yicha sotuv rentabelligi|ADVB: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi Genprex|Sof marja Sunshine Biopharma, Inc.|Sotuvning sof marjinal rentabelligi xeneticbio.com|Sof marja Salarius (SLRX)|Sof foyda bo'yicha sotuv rentabelligi Purple Biotech PPBT|Sof marja American Oncology Network, Inc. AONC|BeiGene, Ltd. (BGNE) - Sof marja|Checkpoint Therapeutics Inc. - Sotuvning sof marjinal rentabelligi|Sof foyda normasi ELEV (Elevation Oncology)|ICAD (iCAD Corp) - Sof foyda bo'yicha sotuv rentabelligi|Ikena Oncology, Inc. - Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi NTBL|VIRX: Sof foyda normasi|Sof marja MorphoSys Corporation (MOR)|NAYA - Sof marja|Sotuvning sof marjinal rentabelligi AAPGV (Ascentage)